INCREASED NAUSEA AND VOMITING INDUCED BY NALOXONE IN PATIENTS RECEIVING CANCER-CHEMOTHERAPY

被引:0
|
作者
KOBRINSKY, NL [1 ]
PRUDEN, PB [1 ]
CHEANG, MS [1 ]
LEVITT, M [1 ]
BISHOP, AJ [1 ]
TENENBEIN, M [1 ]
机构
[1] UNIV MANITOBA, FAC MED, DEPT PEDIAT & CHILD HLTH, WINNIPEG R3E 0V9, MANITOBA, CANADA
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:A300 / A300
页数:1
相关论文
共 50 条
  • [41] REGULATION OF NAUSEA AND VOMITING IN CANCER-CHEMOTHERAPY - A REVIEW WITH EMPHASIS ON OPIATE MEDIATORS
    KOBRINSKY, NL
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1988, 10 (03): : 209 - 213
  • [42] Psychological variables related to anticipatory nausea and vomiting in cancer patients receiving chemotherapy
    Horne, DJD
    Shardey, V
    Greenwood, K
    PSYCHO-ONCOLOGY, 1998, 7 (03) : 185 - 185
  • [43] Control of Nausea and Vomiting in Patients Receiving Anthracycline/Cyclophosphamide Chemotherapy for Breast Cancer
    Nawa-Nishigaki, Minako
    Kobayashi, Ryo
    Suzuki, Akio
    Hirose, Chiemi
    Matsuoka, Rie
    Mori, Ryutaro
    Futamura, Manabu
    Sugiyama, Tadashi
    Yoshida, Kazuhiro
    Itoh, Yoshinori
    ANTICANCER RESEARCH, 2018, 38 (02) : 877 - 884
  • [44] Prevention of chemotherapy-induced nausea and vomiting in patients receiving ifosfamide: High dose chemotherapy
    Talarmin, C.
    Herpin, C.
    Bayle, A.
    Fayard, C.
    Le Cesne, A.
    Mir, O.
    Lemare, F.
    Paret, A.
    Netzer, F.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S156 - S156
  • [45] Rolapitant for the prevention of chemotherapy-induced nausea and vomiting in breast cancer patients receiving multiple cycles of emetogenic chemotherapy
    Schwartzberg, L.
    Navari, R.
    Arora, S.
    Powers, D.
    Jordan, K.
    Rapoport, B.
    CANCER RESEARCH, 2017, 77
  • [46] Analysis of pharmacogenomic factors for chemotherapy-induced nausea and vomiting in patients with breast cancer receiving doxorubicin and cyclophosphamide chemotherapy
    Daiki Tsuji
    Megumi Matsumoto
    Yohei Kawasaki
    Yong-I. L. Kim
    Keisuke Yamamoto
    Hidenori Nakamichi
    Yuri Sahara
    Ryo Makuta
    Mari Yokoi
    Takehiro Miyagi
    Kunihiko Itoh
    Cancer Chemotherapy and Pharmacology, 2021, 87 : 73 - 83
  • [47] Genetic risk factors for chemotherapy-induced nausea and vomiting in patients with cancer receiving cisplatin-based chemotherapy
    Mari Yokoi
    Daiki Tsuji
    Kenichi Suzuki
    Yohei Kawasaki
    Masahiko Nakao
    Hideaki Ayuhara
    Yuuki Kogure
    Kazuhiko Shibata
    Toshinobu Hayashi
    Keita Hirai
    Kazuyuki Inoue
    Toshihiro Hama
    Koji Takeda
    Makoto Nishio
    Kunihiko Itoh
    Supportive Care in Cancer, 2018, 26 : 1505 - 1513
  • [48] Managing chemotherapy-induced nausea and vomiting in head and neck cancer patients receiving cisplatin chemotherapy with concurrent radiation
    Stinson, Jordan
    Chan, Kelvin
    Lee, Justin
    Chow, Ronald
    Cheon, Paul
    Giotis, Angie
    Pasetka, Mark
    Wan, Bo Angela
    Chow, Edward
    DeAngelis, Carlo
    ANNALS OF PALLIATIVE MEDICINE, 2017, 6 : S13 - S20
  • [49] Analysis of pharmacogenomic factors for chemotherapy-induced nausea and vomiting in patients with breast cancer receiving doxorubicin and cyclophosphamide chemotherapy
    Tsuji, Daiki
    Matsumoto, Megumi
    Kawasaki, Yohei
    Kim, Yong-I. L.
    Yamamoto, Keisuke
    Nakamichi, Hidenori
    Sahara, Yuri
    Makuta, Ryo
    Yokoi, Mari
    Miyagi, Takehiro
    Itoh, Kunihiko
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (01) : 73 - 83
  • [50] Genetic risk factors for chemotherapy-induced nausea and vomiting in patients with cancer receiving cisplatin-based chemotherapy
    Yokoi, Mari
    Tsuji, Daiki
    Suzuki, Kenichi
    Kawasaki, Yohei
    Nakao, Masahiko
    Ayuhara, Hideaki
    Kogure, Yuuki
    Shibata, Kazuhiko
    Hayashi, Toshinobu
    Hirai, Keita
    Inoue, Kazuyuki
    Hama, Toshihiro
    Takeda, Koji
    Nishio, Makoto
    Itoh, Kunihiko
    SUPPORTIVE CARE IN CANCER, 2018, 26 (05) : 1505 - 1513